QUVIVIQ
QUVIVIQ
Approved
DIN Number
02537443
Drug Class
Human
Market Date
Jul 12, 2023
Company
HC
Idorsia Pharmaceuticals Ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02537443
AIG Number0164601002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05CJ03 DARIDOREXANT
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:24.40
Health Canada Classification
ACTIVE INGREDIENTS (1)
DARIDOREXANT (DARIDOREXANT HYDROCHLORIDE)Active
Strength: 50 MG
Monograph: DARIDOREXANT (DARIDOREXANT HYDROCHLORIDE)